A novel 21‐kDa protein as a serum marker for benign and malignant urogenital tumors: Preliminary communication
Channa Shalitin(Technion – Israel Institute of Technology), Eliezer Robinson, Ron Epelbaum(University of Bern), B. Lover, Ruth Segal(Rambam Health Care Campus), Clari Valansi(Technion – Israel Institute of Technology), T. Mekori(Rambam Health Care Campus)
Cited by 6
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279